Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC4626 Sbi-0069332
Novel potentiator of metabotropic glutamate receptors for use against neurological and psychiatric disorders
More description
DCC4625 Sbi-0061869
Novel potentiator of metabotropic glutamate receptors for use against neurological and psychiatric disorders
More description
DCC4624 Sbfi-am
Membrane-permeant, fluorescent, selective Na+ indicator dye
More description
DCC4623 Sbc219
Novel cAMP-independent potentiator of CFTR, synergistically restoring CFTR function
More description
DCC4622 Sbc040
Novel cAMP-independent potentiator of CFTR, synergistically restoring CFTR function
More description
DCC4621 Sb-790594-a
Potent non-cytotoxic inhinitor of Mycobacterium tuberculosis H37Rv
More description
DCC4620 Sb-7720770 Dihydrochloride
Novel Rho kinase inhibitor
More description
DCC4619 Sb-744941
Novel inhibitor of mitogen and Stress-Activated Kinases 1 (MSK1)
More description
DCC4618 Sb-656933
Novel CXCR2 selective antagonist, inhibiting ex vivo neutrophil activation and ozone-induced airway inflammation in humans
More description
DCC4617 sb-649915
Novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor
More description
DCC4616 Sb-414796
Potent and selective dopamine D3 receptor antagonist
More description
DCC4615 Sb-390570
Novel TRPV4 blocker
More description
DCC4614 Sb-354364
AntiMycobacterium tuberculosis agent
More description
DCC4613 Sb-284851-bt
Selective p38a kinase inhibitor, inhibiting Brd4
More description
DCC4612 Sb-277011a Dihydrochloride
Selective dopamine D3 receptor antagonist
More description
DCC4611 Sb-267268
Nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reducing angiogenesis and VEGF expression
More description
DCC4610 Sb2602
Novel selective mTOR inhibitor
More description
DCC4609 sb-258719 Hydrochloride
Selective 5-HT7 receptor antagonist
More description
DCC4608 Sb-243213 Dihydrochloride
Selective 5-HT2C_receptor>5-HT2C inverse agonist
More description
DCC4607 Sb-239272
Inhibitor of p38 MAPK
More description
DCC4606 Sb-226552
Potent and selective agonist for the human ß3-adrenoceptor
More description
DCC4605 Sb-220025 Trihydrochloride
Potent, specific inhibitor of human p38 mitogen-activated protein (MAP) kinase
More description
DCC4604 Sb-209670
Dual ETA and ETB receptor antagonist
More description
DCC4603 Sb-203347
Selective, active-site-directed 14 kDa PLA2 inhibitor, totally inhibiting LT and PAF formation, while prostanoid formation was not altered
More description
DCC4602 Sb1617
Novel neuroprotective agent, suppressing abnormal tau protein aggregation
More description
DCC4601 Sb1495
Novel reversible covalent inhibitor of the cyclin-dependent kinase 5 (Cdk5)-mediated phosphorylation of PPARγ at Ser245, a key factor in the insulin-sensitizing effect of PPARγ-targeted drugs
More description
DCC4600 Sb1404
PPARγ covalent ligand
More description
DCC4599 Sazetidine-a Dihydrochloride
Subtype-selective α4β2 nicotinic acetylcholine receptor partial agonist
More description
DCC4598 Saussureamine C
Inhibitor of H274Y and N294S mutants
More description
DCC4597 Sat-in-3
Novel inhibitor of salmonella serine acetyltransferase (SAT), the enzyme that catalyzes the rate-limiting step of L-cysteine biosynthesis
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X